Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-30

Clinical Trial Update: Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects [Phase 2]

View source ↗

Summary

Phase 2 trial updating bioavailability of EPA + DHA enriched canned tuna and its acute effects in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPA + DHA enriched canned tuna

Snippet

Sponsor: Universidade do Porto | Conditions: Healthy Volunteers | Phase 2 | Status: UNKNOWN